Neuberger Berman Group
BPMC

Neuberger Berman Group’s Blueprint Medicines BPMC Stock Holding History

Neuberger Berman Group’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,421
Closed -$310K – 2054
2025
Q2 		$310K Sell
2,421
-65,373
-96% -$6.79M ﹤0.01% 1719
2025
Q1 		$6M Buy
67,794
+1,399
+2% +$136K 0.01% 901
2024
Q4 		$5.79M Buy
66,395
+2,516
+4% +$230K ﹤0.01% 921
2024
Q3 		$5.91M Buy
63,879
+10,110
+19% +$1M ﹤0.01% 910
2024
Q2 		$5.8M Buy
53,769
+2,461
+5% +$246K ﹤0.01% 878
2024
Q1 		$4.87M Sell
51,308
-33,704
-40% -$2.89M ﹤0.01% 932
2023
Q4 		$7.84M Buy
85,012
+28,245
+50% +$1.83M ﹤0.01% 967
2023
Q3 		$2.85M Buy
56,767
+366
+0.6% +$19.6K ﹤0.01% 1008
2023
Q2 		$3.56M Buy
56,401
+13,225
+31% +$719K ﹤0.01% 967
2023
Q1 		$1.94M Buy
43,176
+3,736
+9% +$168K ﹤0.01% 1094
2022
Q4 		$1.73M Buy
39,440
+11,477
+41% +$550K ﹤0.01% 1103
2022
Q3 		$1.84M Buy
+27,963
New +$1.8M ﹤0.01% 1102
2020
Q1 		– Sell
-10,000
Closed -$801K – 1534
2019
Q4 		$801K Sell
10,000
-12,500
-56% -$936K ﹤0.01% 1198
2019
Q3 		$1.65M Sell
22,500
-6,100
-21% -$527K ﹤0.01% 1053
2019
Q2 		$2.7M Buy
28,600
+8,600
+43% +$710K ﹤0.01% 963
2019
Q1 		$1.6M Buy
+20,000
New +$1.48M ﹤0.01% 1010
2018
Q2 		– Sell
-9,711
Closed -$890K – 1708
2018
Q1 		$890K Sell
9,711
-289
-3% -$24.9K ﹤0.01% 1218
2017
Q4 		$754K Buy
+10,000
New +$704K ﹤0.01% 1303
2017
Q2 		– Sell
-16,479
Closed -$659K – 1594
2017
Q1 		$659K Buy
16,479
+5,861
+55% +$210K ﹤0.01% 1239
2016
Q4 		$298K Buy
+10,618
New +$320K ﹤0.01% 1417

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Neuberger Berman Group's BPMC Position: Q3 2025 in Review

Neuberger Berman Group sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 2,421 shares — an estimated $310K sold.

Neuberger Berman Group first reported a position in BPMC in Q4 2016 and held it in 20 quarters. The position peaked at $7.84M in Q4 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Neuberger Berman Group reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Neuberger Berman Group sold 2,421 Blueprint Medicines shares in Q3 2025, an estimated $310K.
  • Neuberger Berman Group first reported a position in Blueprint Medicines in Q4 2016 and held it in 20 quarters.
  • Neuberger Berman Group's Blueprint Medicines position peaked at $7.84M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Neuberger Berman Group's 13F filing for Q3 2025, filed 12 Nov 2025.